Chemicals utilized in the production of fentanyl are entering the Port of Vancouver and heading to drug facilities operated by Mexican cartels within Canada, as stated by the chief of the U.S. Drug Enforcement Administration during a Senate hearing in Washington, D.C. The DEA administrator, Terrance Cole, highlighted the awareness of fentanyl production in Canada for export to the U.S., noting notable drug seizures in Canada recently. Cole addressed a U.S. Senate appropriations committee session focusing on budget requests from federal law enforcement agencies like the DEA and FBI.
In response to a question from Republican Senator Deb Fischer about changes in the drug trade, Cole briefly discussed fentanyl trafficking from Mexico before shifting the focus to Canada. He emphasized the importance of monitoring the northern border, pointing out an increase in precursor substances entering the Port of Vancouver destined for various locations in Canada for drug manufacturing, including fentanyl production in collaboration with Mexican cartels.
The issue of fentanyl trafficking from Canada has been a significant concern for U.S. President Donald Trump, leading to the imposition of tariffs on Canadian goods. Despite evidence indicating that Canada is a minor source of fentanyl entering the U.S., concerns persist and efforts to combat cross-border trafficking have been promised by Ottawa.
The U.S. DEA currently maintains two offices in Canada and plans to open two additional offices in 2027 to enhance monitoring and enforcement activities in the country. Statistics from the 2025 fiscal year show that fentanyl seizures along the northern border pale in comparison to those along the Mexican border, with a notable increase in seizures at the latter.
Authorities in Vancouver responded to Cole’s remarks by highlighting collaborative efforts with law enforcement agencies to ensure secure trade through the port. The Canadian Border Services Agency emphasized the country’s commitment to strengthening border security and combating illicit drug trafficking.
Despite ongoing efforts by the Canadian government to address drug production and trafficking, Trump’s concerns resulted in the imposition of tariffs, which were later overturned by the U.S. Supreme Court. The regulatory landscape surrounding cross-border drug trafficking remains a significant issue impacting trade relations between the U.S. and Canada.
